These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 29992845

  • 1. Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: the ESSENCE study.
    Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, Baimukhamedov C, Omarbekova Z, Iaremenko O, Gnylorybov A, Shevchuk S, Vasylyev A, Makarova J, Tariq L.
    J Med Econ; 2018 Oct; 21(10):1006-1015. PubMed ID: 29992845
    [Abstract] [Full Text] [Related]

  • 2. Standard medical care of patients with systemic lupus erythematosus (SLE) in large specialised centres: data from the Russian Federation, Ukraine and Republic of Kazakhstan (ESSENCE).
    Nasonov E, Soloviev S, Davidson JE, Lila A, Togizbayev G, Ivanova R, Baimukhamedov Ch, Omarbekova Zh, Iaremenko O, Gnylorybov A, Shevchuk S, Vasylyev A, Pereira MH.
    Lupus Sci Med; 2015 Oct; 2(1):e000060. PubMed ID: 25717382
    [Abstract] [Full Text] [Related]

  • 3. The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan).
    Nasonov E, Soloviev S, Davidson JE, Lila A, Ivanova R, Togizbayev G, Omarbekova Z, Shevchuk S, Iaremenko O, Gnylorybov A, Smailova Z, Chernogolov V, Malynovska K, Vasylyev A, Pereira MH.
    Lupus; 2014 Feb; 23(2):213-9. PubMed ID: 24255073
    [Abstract] [Full Text] [Related]

  • 4. Annual direct medical cost of active systemic lupus erythematosus in five European countries.
    Doria A, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I.
    Ann Rheum Dis; 2014 Jan; 73(1):154-60. PubMed ID: 23264339
    [Abstract] [Full Text] [Related]

  • 5. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
    Doria A, Iaccarino L, La Montagna G, Mathieu A, Piga M, Galeazzi M, Iuliano A, Maurel FB, Garofano AM, Perna AG, Porcasi RE.
    Clin Exp Rheumatol; 2015 Jan; 33(3):375-84. PubMed ID: 26005879
    [Abstract] [Full Text] [Related]

  • 6. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
    Garris C, Jhingran P, Bass D, Engel-Nitz NM, Riedel A, Dennis G.
    J Med Econ; 2013 Jan; 16(5):667-77. PubMed ID: 23425294
    [Abstract] [Full Text] [Related]

  • 7. [Cost of systemic lupus erythematosus for adult patients with active and treated disease in France (LUCIE study)].
    Amoura Z, Deligny C, Pennaforte JL, Hamidou M, Blanco P, Hachulla E, Pourrat J, Queyrel V, Garofano A, Maurel F, Levy-Bachelot L, Boucot I.
    Rev Med Interne; 2014 Nov; 35(11):700-8. PubMed ID: 24630588
    [Abstract] [Full Text] [Related]

  • 8. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
    Cervera R, Rúa-Figueroa I, Gil-Aguado A, Sabio JM, Pallarés L, Hernández-Pastor LJ, Iglesias M.
    Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
    [Abstract] [Full Text] [Related]

  • 9. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
    Oglesby A, Korves C, Laliberté F, Dennis G, Rao S, Suthoff ED, Wei R, Duh MS.
    Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
    [Abstract] [Full Text] [Related]

  • 10. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C, Sruamsiri R, Mahlich J, Jung W.
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [Abstract] [Full Text] [Related]

  • 11. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
    Clarke AE, Urowitz MB, Monga N, Hanly JG.
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
    [Abstract] [Full Text] [Related]

  • 12. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
    Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER.
    Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
    [Abstract] [Full Text] [Related]

  • 13. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
    Tanaka Y, Mizukami A, Kobayashi A, Ito C, Matsuki T.
    Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
    [Abstract] [Full Text] [Related]

  • 14. Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA.
    Bell CF, Priest J, Stott-Miller M, Kan H, Amelio J, Song X, Limone B, Noxon V, Costenbader KH.
    Lupus Sci Med; 2020 Aug; 7(1):e000357. PubMed ID: 32341790
    [Abstract] [Full Text] [Related]

  • 15. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY, Tam LS, Lee VW, Lee KK, Li EK.
    Arthritis Rheum; 2009 Sep 15; 61(9):1159-67. PubMed ID: 19714597
    [Abstract] [Full Text] [Related]

  • 16. Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay.
    Aldarmaki R, Al Khogali HI, Al Dhanhani AM.
    Lupus; 2021 Apr 15; 30(5):845-851. PubMed ID: 33497303
    [Abstract] [Full Text] [Related]

  • 17. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.
    Clin Ther; 2009 Nov 15; 31(11):2653-64. PubMed ID: 20110008
    [Abstract] [Full Text] [Related]

  • 18. Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
    Katz P, Nelson WW, Daly RP, Topf L, Connolly-Strong E, Reed ML.
    J Manag Care Spec Pharm; 2020 Mar 15; 26(3):275-283. PubMed ID: 32105178
    [Abstract] [Full Text] [Related]

  • 19. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
    Lokhandwala T, Coutinho AD, Bell CF.
    Clin Ther; 2021 Aug 15; 43(8):1320-1335. PubMed ID: 34243966
    [Abstract] [Full Text] [Related]

  • 20. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA, Bruce IN, Gordon C, Isenberg DA, Ateka-Barrutia O, Gayed M, Donatti C, Guillermin AL, Foo J, Perna A.
    Lupus; 2014 Mar 15; 23(3):273-83. PubMed ID: 24356612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.